» Articles » PMID: 21161005

Simultaneous Occurrence of a Hepatocellular Carcinoma and a Hepatic Non-Hodgkin's Lymphoma Infiltration

Overview
Journal World J Hepatol
Specialty Gastroenterology
Date 2010 Dec 17
PMID 21161005
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

To investigate the simultaneous occurrence of hepatocellular carcinoma and non-Hodgkin's lymphoma, we report the case of a 70 year old patient with a primary diagnosis of non-Hodgkin's lymphoma in 2002. In a routine follow up investigation of his chronic lymphocytic leukemia a newly detected mass in the Couinaud's segments 2 and 3 was found. No hepatitis C virus or hepatitis B virus infection or cirrhosis was evident. After laparoscopic segmentectomy the histological examination revealed a hepatocellular carcinoma. While the relation between liver parenchyma damages and hepatocellular carcinoma or non-Hodgkin's lymphoma is well known, only a few publications have focused on the coexistence of hepatocellular carcinoma and non-Hodgkin's lymphoma. With this case we demonstrate the coexistence of these diseases without having a predamaged liver parenchyma.

Citing Articles

Hepatocellular Carcinoma With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma in the Absence of Cirrhosis.

Tu B, Khalyfa A, Bellizzi A, Tanaka T ACG Case Rep J. 2024; 11(5):e01348.

PMID: 38725478 PMC: 11081597. DOI: 10.14309/crj.0000000000001348.


Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.

Li Q, Dong Y, Pan Y, Tang H, Li D Front Immunol. 2021; 12:634559.

PMID: 33868256 PMC: 8044442. DOI: 10.3389/fimmu.2021.634559.


Coexistence of hepatoma with mantle cell lymphoma in a hepatitis B carrier.

Lee M, Lin Y, Cheng H, Chuang W, Huang H, Kao H World J Gastroenterol. 2015; 21(45):12981-6.

PMID: 26668520 PMC: 4671051. DOI: 10.3748/wjg.v21.i45.12981.

References
1.
Xiong X, Qiu F, Fang J, Shen Y, Liang C, Jiang W . Association analysis between the Cdc6 G1321A polymorphism and the risk for non-Hodgkin lymphoma and hepatocellular carcinoma. Mutat Res. 2008; 662(1-2):10-5. DOI: 10.1016/j.mrfmmm.2008.11.014. View

2.
Kataoka T, Tsukamoto Y, Kanazawa N, Izumi T, Awata N, Nishizawa Y . Concomitant hepatocellular carcinoma and non-Hodgkin's lymphoma in a patient with nodular regenerative hyperplasia. Pathol Int. 2006; 56(5):279-82. DOI: 10.1111/j.1440-1827.2006.01956.x. View

3.
Schutte K, Bornschein J, Malfertheiner P . Hepatocellular carcinoma--epidemiological trends and risk factors. Dig Dis. 2009; 27(2):80-92. DOI: 10.1159/000218339. View

4.
El-Serag H . Hepatocellular carcinoma and hepatitis C in the United States. Hepatology. 2002; 36(5 Suppl 1):S74-83. DOI: 10.1053/jhep.2002.36807. View

5.
Loddenkemper C, Longerich T, Hummel M, Ernestus K, Anagnostopoulos I, Dienes H . Frequency and diagnostic patterns of lymphomas in liver biopsies with respect to the WHO classification. Virchows Arch. 2007; 450(5):493-502. PMC: 1888718. DOI: 10.1007/s00428-007-0384-9. View